• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蓄势待发,探索无限。

Primed for Discovery.

机构信息

Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37240, United States.

Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee 37232, United States.

出版信息

Biochemistry. 2024 Nov 5;63(21):2705-2713. doi: 10.1021/acs.biochem.4c00464. Epub 2024 Oct 15.

DOI:10.1021/acs.biochem.4c00464
PMID:39497571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11542185/
Abstract

Antibiotics are essential components of current medical practice, but their effectiveness is being eroded by the increasing emergence of antimicrobial-resistant infections. At the same time, the rate of antibiotic discovery has slowed, and our future ability to treat infections is threatened. Among Christopher T. Walsh's many contributions to science was his early recognition of this threat and the potential of biosynthesis─genes and mechanisms─to contribute solutions. Here, we revisit a 2006 review by Walsh and co-workers that highlighted a major challenge in antibiotic natural product discovery: the daunting odds for identifying new naturally occurring antibiotics. The review described strategies to mitigate the odds challenge. These strategies have been used extensively by the natural product discovery community in the years since and have resulted in some promising discoveries. Despite these advances, the rarity of novel antibiotic natural products remains a barrier to discovery. We compare the challenge of discovering natural product antibiotics to the process of identifying new prime numbers, which are also challenging to find and an essential, if underappreciated, element of modern life. We propose that inclusion of filters for functional compounds early in the discovery pipeline is key to natural product antibiotic discovery, review some recent advances that enable this, and discuss some remaining challenges that need to be addressed to make antibiotic discovery sustainable in the future.

摘要

抗生素是当前医学实践的重要组成部分,但由于抗菌药物耐药性感染的不断出现,其疗效正在逐渐减弱。与此同时,抗生素的发现速度已经放缓,我们未来治疗感染的能力受到了威胁。克里斯托弗·T·沃尔什(Christopher T. Walsh)对科学的众多贡献之一是,他很早就意识到了这一威胁,以及生物合成——基因和机制——可能为解决问题提供帮助。在这里,我们重温了沃尔什及其同事在 2006 年发表的一篇综述,该综述强调了抗生素天然产物发现的一个主要挑战:识别新的天然存在的抗生素的几率令人望而却步。该综述描述了减轻几率挑战的策略。这些策略在那之后的几年里被天然产物发现界广泛应用,并取得了一些有前景的发现。尽管取得了这些进展,但新型抗生素天然产物的稀缺性仍然是发现的障碍。我们将发现天然产物抗生素的挑战与识别新素数的过程进行了比较,素数也很难找到,尽管它是现代生活中不可或缺但却被低估的一个元素。我们提出,在发现管道早期纳入针对功能化合物的筛选是发现天然产物抗生素的关键,我们将回顾一些能够实现这一目标的最新进展,并讨论一些需要解决的剩余挑战,以使未来的抗生素发现能够可持续发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b462/11542185/305eae667a8a/bi4c00464_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b462/11542185/305eae667a8a/bi4c00464_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b462/11542185/305eae667a8a/bi4c00464_0001.jpg

相似文献

1
Primed for Discovery.蓄势待发,探索无限。
Biochemistry. 2024 Nov 5;63(21):2705-2713. doi: 10.1021/acs.biochem.4c00464. Epub 2024 Oct 15.
2
Natural products as a source of drug leads to overcome drug resistance.天然产物作为药物先导物的来源以克服耐药性。
Future Microbiol. 2015;10(11):1711-8. doi: 10.2217/fmb.15.67. Epub 2015 Oct 30.
3
Something old, something new: revisiting natural products in antibiotic drug discovery.旧药新用:重新审视天然产物在抗生素药物研发中的作用。
Can J Microbiol. 2014 Mar;60(3):147-54. doi: 10.1139/cjm-2014-0063. Epub 2014 Jan 22.
4
The Antibiotic Resistome: A Guide for the Discovery of Natural Products as Antimicrobial Agents.抗生素耐药组:天然产物作为抗菌剂的发现指南。
Chem Rev. 2021 Mar 24;121(6):3464-3494. doi: 10.1021/acs.chemrev.0c01214. Epub 2021 Feb 19.
5
Next-Generation Drug Discovery to Combat Antimicrobial Resistance.下一代药物发现以对抗抗微生物药物耐药性。
Trends Biochem Sci. 2019 Nov;44(11):961-972. doi: 10.1016/j.tibs.2019.05.005. Epub 2019 Jun 27.
6
Interplay of emerging and established technologies drives innovation in natural product antibiotic discovery.新兴技术和成熟技术的相互作用推动了天然产物抗生素发现的创新。
Curr Opin Microbiol. 2023 Oct;75:102359. doi: 10.1016/j.mib.2023.102359. Epub 2023 Jul 28.
7
Strategies for target identification of antimicrobial natural products.抗菌天然产物的靶标鉴定策略。
Nat Prod Rep. 2016 May 4;33(5):668-80. doi: 10.1039/c5np00127g.
8
Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.利用海洋天然产物作为平台来解决细菌耐药性和持久性问题。
Acc Chem Res. 2021 Apr 20;54(8):1866-1877. doi: 10.1021/acs.accounts.1c00007. Epub 2021 Mar 18.
9
Current challenges in the discovery of novel antibacterials from microbial natural products.从微生物天然产物中发现新型抗菌药物的当前挑战。
Recent Pat Antiinfect Drug Discov. 2012 Dec 1;7(3):189-204. doi: 10.2174/157489112803521968.
10
Antibiotic drug discovery.抗生素药物发现
Microb Biotechnol. 2016 Sep;9(5):541-8. doi: 10.1111/1751-7915.12388. Epub 2016 Jul 29.

本文引用的文献

1
BGC Atlas: a web resource for exploring the global chemical diversity encoded in bacterial genomes.BGC图谱:一个用于探索细菌基因组中编码的全球化学多样性的网络资源。
Nucleic Acids Res. 2025 Jan 6;53(D1):D618-D624. doi: 10.1093/nar/gkae953.
2
Macrolones target bacterial ribosomes and DNA gyrase and can evade resistance mechanisms.大环内酯类药物靶向细菌核糖体和 DNA 回旋酶,可逃避耐药机制。
Nat Chem Biol. 2024 Dec;20(12):1680-1690. doi: 10.1038/s41589-024-01685-3. Epub 2024 Jul 22.
3
Natural Products Have Increased Rates of Clinical Trial Success throughout the Drug Development Process.
天然产物在整个药物研发过程中提高了临床试验成功率。
J Nat Prod. 2024 Jul 26;87(7):1844-1851. doi: 10.1021/acs.jnatprod.4c00581. Epub 2024 Jul 6.
4
An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance.一种预先设计用于与核糖体结合的抗生素克服了抗微生物耐药性。
Science. 2024 Feb 16;383(6684):721-726. doi: 10.1126/science.adk8013. Epub 2024 Feb 15.
5
Predicting fungal secondary metabolite activity from biosynthetic gene cluster data using machine learning.基于生物合成基因簇数据利用机器学习预测真菌次生代谢物活性。
Microbiol Spectr. 2024 Feb 6;12(2):e0340023. doi: 10.1128/spectrum.03400-23. Epub 2024 Jan 9.
6
Discovery of a structural class of antibiotics with explainable deep learning.发现具有可解释深度学习的抗生素结构类别。
Nature. 2024 Feb;626(7997):177-185. doi: 10.1038/s41586-023-06887-8. Epub 2023 Dec 20.
7
RefSeq and the prokaryotic genome annotation pipeline in the age of metagenomes.RefSeq 与宏基因组时代的原核生物基因组注释流程。
Nucleic Acids Res. 2024 Jan 5;52(D1):D762-D769. doi: 10.1093/nar/gkad988.
8
A Multi-Label Learning Framework for Predicting Chemical Classes and Biological Activities of Natural Products from Biosynthetic Gene Clusters.一种用于从生物合成基因簇预测天然产物化学类别和生物活性的多标签学习框架。
J Chem Ecol. 2023 Dec;49(11-12):681-695. doi: 10.1007/s10886-023-01452-z. Epub 2023 Oct 2.
9
Fitness Costs of Antibiotic Resistance Impede the Evolution of Resistance to Other Antibiotics.抗生素耐药性的适应成本会阻碍对其他抗生素产生耐药性的进化。
ACS Infect Dis. 2023 Oct 13;9(10):1834-1845. doi: 10.1021/acsinfecdis.3c00156. Epub 2023 Sep 19.
10
An antibiotic from an uncultured bacterium binds to an immutable target.一种来自未培养细菌的抗生素与一个不变的靶标结合。
Cell. 2023 Sep 14;186(19):4059-4073.e27. doi: 10.1016/j.cell.2023.07.038. Epub 2023 Aug 22.